These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


64 related items for PubMed ID: 1571339

  • 1. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR, Lake KD, Reutzel TJ, Hoffman FM, Jorgensen CR, Pederson W, Emery RW.
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [Abstract] [Full Text] [Related]

  • 2. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [Abstract] [Full Text] [Related]

  • 3. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A, Macdonald P, Harvison A, Richens D, Mundy J, Spratt P.
    J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [Abstract] [Full Text] [Related]

  • 4. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT, Jessen ME, Baldwin BJ, Horn VP, Yancy CW, Ring WS, Rosenblatt RL.
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [Abstract] [Full Text] [Related]

  • 5. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW, Wolford T, McBride LR, Peigh P, Pennington DG.
    J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [Abstract] [Full Text] [Related]

  • 6. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
    Lake KD, Reutzel TJ, Pritzker MR, Jorgensen CR, Emery RW.
    J Heart Lung Transplant; 1993; 12(4):580-90. PubMed ID: 8369320
    [Abstract] [Full Text] [Related]

  • 7. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML, Sanchez JA, Seche LA, Schulman LL, Smith CR, Rose EA.
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy.
    Laske A, Gallino A, Schneider J, Bauer EP, Carrel T, Pasic M, von Segesser LK, Turina MI.
    J Heart Lung Transplant; 1992 Apr; 11(3 Pt 1):557-63. PubMed ID: 1610864
    [Abstract] [Full Text] [Related]

  • 10. Initial success of steroid weaning late after heart transplantation.
    Kobashigawa JA, Stevenson LW, Brownfield ED, Moriguchi JD, Kawata N, Fandrich R, Drinkwater DC, Laks H.
    J Heart Lung Transplant; 1992 Apr; 11(2 Pt 2):428-30. PubMed ID: 1571341
    [Abstract] [Full Text] [Related]

  • 11. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L, García-Palomar C, Martínez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Osa A, Cardo ML.
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [Abstract] [Full Text] [Related]

  • 12. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
    Frist WH, Merrill WH, Eastburn TE, Atkinson JB, Stewart JR, Hammon JW, Bender JW.
    J Heart Transplant; 1990 Nov; 9(5):489-94. PubMed ID: 2121921
    [Abstract] [Full Text] [Related]

  • 13. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO, Bristow MR, O'Connell JB, Price GD, Hammond EH, Doty DB, Karwande SV, Gay WA, Jones KW, Lappé D, Renlund DG.
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [Abstract] [Full Text] [Related]

  • 14. Triple-drug immunosuppression for heart transplantation in infants and children.
    Brown JW, Turrentine MW, Kesler KA, Mahomed Y, Darragh R, Evans K, Thompson L, Caldwell R.
    J Heart Lung Transplant; 1993 Oct; 12(6 Pt 2):S265-74. PubMed ID: 8312346
    [Abstract] [Full Text] [Related]

  • 15. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 16. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR.
    J Heart Transplant; 1989 Aug; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [Abstract] [Full Text] [Related]

  • 17. Experience with single-dose daclizumab in the prevention of acute rejection in heart transplantation.
    Cuppoletti A, Perez-Villa F, Vallejos I, Roig E.
    Transplant Proc; 2005 Nov; 37(9):4036-8. PubMed ID: 16386620
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic OKT3 used as induction therapy for heart transplantation.
    Starnes VA, Oyer PE, Stinson EB, Dein JR, Shumway NE.
    Circulation; 1989 Nov; 80(5 Pt 2):III79-83. PubMed ID: 2509108
    [Abstract] [Full Text] [Related]

  • 19. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 20. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM, Reichenspurner H, Uberfuhr P, Kur F, Kaulbach HG, Meiser BM, Ziegler U, Reichart B.
    J Heart Lung Transplant; 1994 Dec; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.